241 related articles for article (PubMed ID: 1909649)
1. Trypanosoma cruzi: T-cell-dependent mechanisms of resistance during chronic infection.
Rottenberg ME; Cardoni RL; Sinagra A; Riarte A; Rodriguez Nantes I; Lauricella M; Segura EL
Exp Parasitol; 1991 Aug; 73(2):127-36. PubMed ID: 1909649
[TBL] [Abstract][Full Text] [Related]
2. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
Muñoz-Fernández MA; Fernández MA; Fresno M
Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
[TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
Abrahamsohn IA; Coffman RL
Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
Hoft DF; Lynch RG; Kirchhoff LV
J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
[TBL] [Abstract][Full Text] [Related]
5. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
[TBL] [Abstract][Full Text] [Related]
7. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein.
Duthie MS; Wleklinski-Lee M; Smith S; Nakayama T; Taniguchi M; Kahn SJ
Infect Immun; 2002 Jan; 70(1):36-48. PubMed ID: 11748161
[TBL] [Abstract][Full Text] [Related]
8. Extracellular Vesicles Shed By
Lovo-Martins MI; Malvezi AD; Zanluqui NG; Lucchetti BFC; Tatakihara VLH; Mörking PA; de Oliveira AG; Goldenberg S; Wowk PF; Pinge-Filho P
Front Immunol; 2018; 9():896. PubMed ID: 29755471
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice.
Aliberti JC; Machado FS; Gazzinelli RT; Teixeira MM; Silva JS
Infect Immun; 1999 Jun; 67(6):2810-4. PubMed ID: 10338485
[TBL] [Abstract][Full Text] [Related]
10. Early IFN-gamma production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections.
Antúnez MI; Cardoni RL
Immunol Lett; 2001 Dec; 79(3):189-96. PubMed ID: 11600197
[TBL] [Abstract][Full Text] [Related]
11. Vaccination of mice with a combination of BCG and killed Leishmania promastigotes reduces acute Trypanosoma cruzi infection by promoting an IFN-gamma response.
Araujo Z; El Bouhdidi A; Heremans H; Van Marck E; Castés M; Carlier Y
Vaccine; 1999 Feb; 17(7-8):957-64. PubMed ID: 10067703
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic lymphocytes treated with IgG from Trypanosoma cruzi infection increase TNF-alpha secretion and reduce parasite replication in macrophages.
Montalvão F; Almeida GM; Silva EM; Borges VM; Vasconcellos R; Takiya CM; Lopes MF; Nunes MP; DosReis GA
Eur J Immunol; 2010 Feb; 40(2):417-25. PubMed ID: 19950177
[TBL] [Abstract][Full Text] [Related]
13. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
Reed SG
J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
[TBL] [Abstract][Full Text] [Related]
14. NK1.1+ cells and T-cell activation in euthymic and thymectomized C57Bl/6 mice during acute Trypanosoma cruzi infection.
Cardillo F; Cunha FQ; Tamashiro WM; Russo M; Garcia SB; Mengel J
Scand J Immunol; 2002 Jan; 55(1):96-104. PubMed ID: 11841697
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-12 stimulation of lymphoproliferative responses in Trypanosoma cruzi infection.
Galvão da Silva AP; de Almeida Abrahamsohn I
Immunology; 2001 Nov; 104(3):349-54. PubMed ID: 11722650
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived macrophages grown in GM-CSF or M-CSF differ in their ability to produce IL-12 and to induce IFN-gamma production after stimulation with Trypanosoma cruzi antigens.
Tadokoro CE; de Almeida Abrahamsohn I
Immunol Lett; 2001 May; 77(1):31-8. PubMed ID: 11348667
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro effects of cyclosporin A on Trypanosoma cruzi.
McCabe RE; Remington JS; Araujo FG
Am J Trop Med Hyg; 1985 Sep; 34(5):861-5. PubMed ID: 3929634
[TBL] [Abstract][Full Text] [Related]
18. Differential CD86 and CD40 co-stimulatory molecules and cytokine expression pattern induced by Trypanosoma cruzi in APCs from resistant or susceptible mice.
Planelles L; Thomas MC; Marañón C; Morell M; López MC
Clin Exp Immunol; 2003 Jan; 131(1):41-7. PubMed ID: 12519384
[TBL] [Abstract][Full Text] [Related]
19. Challenge of Trypanosoma cruzi chronically infected mice with trypomastigotes activates the immune system and reduces subpatent parasitemia levels.
Marinho CR; Bastos KR; Sardinha LR; Grisotto MG; Lima MR; Alvarez JM
J Parasitol; 2004 Jun; 90(3):516-23. PubMed ID: 15270095
[TBL] [Abstract][Full Text] [Related]
20. Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts.
Nunes MP; Andrade RM; Lopes MF; DosReis GA
J Immunol; 1998 Feb; 160(3):1313-9. PubMed ID: 9570549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
